Pediatric Long-Term Follow-up and Rollover Study
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Astrocytoma
- Anaplastic Oligodendroglioma
- Anaplastic Astrocytoma
- Pilocytic Astrocytoma
- Dysplastic Gangliocytoma of Cerebrellum
- Neurofibromatosis Type 1
- Oligodendroglioma, Childhood
- Anaplastic Ganglioglioma
- Anaplastic Pleomorphic Xanthoastrocytoma
- Pleomorphic Xanthoastrocytoma
- Rosette-forming Glioneurona Tumor
- Glioblastoma
- Papillary Glioneuronal Tumor
- Angiocentric Glioma
- Gangliocytoma
- Extraventricular Neurocytoma
- Giant Cell Astrocytoma
- Central Neurocytoma
- Cerebellar Liponeurocytoma
- Ganglioglioma
- Chordoid Glioma of Third Ventricle
- Desmoplastic Infantile Astrocytoma and Ganglioglioma
- Diffuse Astrocytoma
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 1 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03975829
- Collaborators
- Not Provided
- Investigators
- Study Director: Novartis Pharmaceuticals Novartis Pharmaceuticals
Get Well Soon